Showing results (381-390 of 452) with videos related to

Sort By:
Pageof 46
The New Microbiologica|May 5, 2015
Direct identification of microorganisms from positive blood cultures using the lysis-filtration technique and matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS): a multicentre studyClaudio Farina, Fabio Arena, Patrizia Casprini, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 30, 2018
Interconnected clusters of invasive meningococcal disease due to <i>Neisseria meningitidis</i> serogroup C ST-11 (cc11), involving bisexuals and men who have sex with men, with discos and gay-venues hotspots of transmission, Tuscany, Italy, 2015 to 2016Alessandro Miglietta, Cecilia Fazio, Arianna Neri, et al.
European Journal of Immunology|November 25, 2021
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infectionMichele Spinicci, Alessio Mazzoni, Beatrice Borchi, et al.
Microbes and Infection|April 18, 2024
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patientsGiulia Nannini, Leandro Di Gloria, Edda Russo, et al.
Plos Pathogens|July 11, 2022
Widespread emergence of OmpK36 loop 3 insertions among multidrug-resistant clones of Klebsiella pneumoniaeSophia David, Joshua L C Wong, Julia Sanchez-Garrido, et al.
Computational and Structural Biotechnology Journal|September 2, 2022
Computational design and characterization of a multiepitope vaccine against carbapenemase-producing <i>Klebsiella pneumoniae</i> strains, derived from antigens identified through reverse vaccinologyNicola Cuscino, Ayesha Fatima, Vincenzo Di Pilato, et al.
BMC Genomic Data|May 9, 2026
Genomic and molecular characterisation of a KPC-producing Klebsiella pneumoniae clinical isolate resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactamYu Wan, Joshua L C Wong, Julia Sanchez-Garrido, et al.
World Journal of Gastroenterology|March 23, 2022
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapyEdda Russo, Giulia Nannini, Gaetana Sterrantino, et al.
Clinical & Translational Immunology|May 12, 2021
Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individualsAlessio Mazzoni, Laura Maggi, Manuela Capone, et al.
Antimicrobial Agents and Chemotherapy|April 5, 2022
Consensus on β-Lactamase NomenclaturePatricia A Bradford, Robert A Bonomo, Karen Bush, et al.
Pageof 46